海正藥業(600267.SH):部分房產未徵集到受讓方 再次提交掛牌申請
格隆匯1月2日丨海正藥業(600267.SH)公佈,公司於2019年11月5日向上海聯交所提交了上海市松江區小崑山鎮廣富林路4855弄16號、17號廠房和北京市宣武區南濱河路23號3號樓1901室、1902室房產的掛牌申請,相關房產委託上海聯交所通過掛牌方式轉讓,掛牌自2019年11月6日至2019年11月12日止。
截至2019年12月31日,公司公開掛牌轉讓的上述房產延長掛牌期期滿,公司未徵集到符合條件的意向受讓方。公司於2020年1月2日再次向上海聯交所提交了上海市松江區小崑山鎮廣富林路4855弄16號、17號廠房和北京市宣武區南濱河路23號3號樓1901室、1902室房產的掛牌申請,掛牌自2020年1月3日至2020年2月4日止,掛牌期滿後,若未徵集到滿足摘牌條件的意向受讓方,則不變更掛牌條件,按照20個工作日為一個週期延長,最多延長4個週期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.